Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2018 Filed Sep 7, 2018 00:05 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,026 | $129.97 | $263,319.22 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,035,681 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $129.60 to $130.35, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:05 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 6,179 | $129.15 | $798,017.85 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,037,707 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $128.60 to $129.55, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:05 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,945 | $128.11 | $633,503.95 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,043,886 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $127.60 to $128.55, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 04, 2018 Filed Sep 7, 2018 00:05 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 6,783 | $127.06 | $861,847.98 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,048,831 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $126.60 to $127.55, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:51 UTC |
Foukas JoshuaChief Legal Officer
|
Exercise / conversionStock - Settles Stock Appreciation Right · Derivative | 5,152 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-011175 · edgar.xml · derivative · entry 5 Foukas Joshua · CIK 0001748208 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,848 Underlying: Common Stock · 5,152 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:51 UTC |
Foukas JoshuaChief Legal Officer
|
SaleCommon Stock | 2,348 | $130.08 | $305,420.80 |
DisclosureSEC source: 0001179110-18-011175 · edgar.xml · nonDerivative · entry 2 Foukas Joshua · CIK 0001748208 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price $130.077. Price range in multiple transactions was $130.00 to $130.55 inclusively. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:51 UTC |
Foukas JoshuaChief Legal Officer
|
Exercise / conversionCommon Stock | 2,348 | $70.75 | $166,109.26 |
DisclosureSEC source: 0001179110-18-011175 · edgar.xml · nonDerivative · entry 1 Foukas Joshua · CIK 0001748208 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:50 UTC | Exercise / conversionStock - Settles Stock Appreciation Right · Derivative | 4,827 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-011174 · edgar.xml · derivative · entry 7 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,173 Underlying: Common Stock · 4,827 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| September 04, 2018 Filed Sep 6, 2018 22:50 UTC | SaleCommon Stock | 2,200 | $130.08 | $286,176.00 |
DisclosureSEC source: 0001179110-18-011174 · edgar.xml · nonDerivative · entry 2 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price $130.08. Price range in multiple transactions was $130.00 to $130.55 inclusively. Read SEC document |
|
| September 04, 2018 Filed Sep 6, 2018 22:50 UTC | Exercise / conversionCommon Stock | 2,200 | $70.75 | $155,639.00 |
DisclosureSEC source: 0001179110-18-011174 · edgar.xml · nonDerivative · entry 1 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
|
| September 04, 2018 Filed Sep 6, 2018 22:44 UTC |
Brown JimPresident & COO
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 5,266 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-011172 · edgar.xml · derivative · entry 3 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,734 Underlying: Common Stock · 5,266 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:44 UTC |
Brown JimPresident & COO
|
SaleCommon Stock | 2,400 | $130.09 | $312,204.00 |
DisclosureSEC source: 0001179110-18-011172 · edgar.xml · nonDerivative · entry 2 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price $130.085. Price range in multiple transactions was $130.00 to $130.55 inclusively. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:44 UTC |
Brown JimPresident & COO
|
Exercise / conversionCommon Stock | 2,400 | $70.75 | $169,788.00 |
DisclosureSEC source: 0001179110-18-011172 · edgar.xml · nonDerivative · entry 1 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:49 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 5,380 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-011173 · edgar.xml · derivative · entry 3 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,620 Underlying: Common Stock · 5,380 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:49 UTC |
Macuga Daniel A.Chief Communications Officer
|
SaleCommon Stock | 2,452 | $130.09 | $318,968.42 |
DisclosureSEC source: 0001179110-18-011173 · edgar.xml · nonDerivative · entry 2 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price $130.085. Price range in multiple transactions was $130.00 to $130.55 inclusively. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:49 UTC |
Macuga Daniel A.Chief Communications Officer
|
Exercise / conversionCommon Stock | 2,452 | $70.75 | $173,466.74 |
DisclosureSEC source: 0001179110-18-011173 · edgar.xml · nonDerivative · entry 1 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| August 21, 2018 Filed Aug 22, 2018 23:17 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 60,000 | $131.35 | $7,881,000.00 |
DisclosureSEC source: 0001144204-18-045983 · tv501569_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,055,614 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 21, 2018 Filed Aug 22, 2018 23:16 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 60,000 | $131.35 | $7,881,000.00 |
DisclosureSEC source: 0001144204-18-045982 · tv501568_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,055,614 Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 17:46 UTC |
AUCIAUX ROBERTDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010699 · edgar.xml · derivative · entry 3 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 17:46 UTC |
AUCIAUX ROBERTDirector
|
Tax withholdingCommon Stock | 85 | $115.30 | $9,800.50 |
DisclosureSEC source: 0001179110-18-010699 · edgar.xml · nonDerivative · entry 2 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197 Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 17:46 UTC |
AUCIAUX ROBERTDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-010699 · edgar.xml · nonDerivative · entry 1 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 17:46 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
Exercise / conversionStock-Settles Stock appreciation Right · Derivative | 15,355 | $0.00 Strike: $65.48 | $0.00 |
DisclosureSEC source: 0001179110-18-010698 · edgar.xml · derivative · entry 6 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 15,355 shares Expires 2022-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 17:46 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
SaleCommon Stock | 7,530 | $128.73 | $969,309.79 |
DisclosureSEC source: 0001179110-18-010698 · edgar.xml · nonDerivative · entry 4 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: Weighted average price. Price range in multiple transactions was $128.50 to $129.45, inclusive. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 17:46 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,530 | $65.48 | $493,064.40 |
DisclosureSEC source: 0001179110-18-010698 · edgar.xml · nonDerivative · entry 3 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 17:46 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
Exercise / conversionStock-Settles Stock appreciation Right · Derivative | 14,645 | $0.00 Strike: $65.48 | $0.00 |
DisclosureSEC source: 0001179110-18-010698 · edgar.xml · derivative · entry 5 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,355 Underlying: Common Stock · 14,645 shares Expires 2022-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 17:46 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
SaleCommon Stock | 7,211 | $129.39 | $932,998.84 |
DisclosureSEC source: 0001179110-18-010698 · edgar.xml · nonDerivative · entry 2 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price. Price range in multiple transactions was $129.00 to $129.90, inclusive. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 17:46 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,211 | $65.48 | $472,176.28 |
DisclosureSEC source: 0001179110-18-010698 · edgar.xml · nonDerivative · entry 1 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II Read SEC document |
| August 09, 2018 Filed Aug 11, 2018 01:13 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 40,000 | $131.00 | $5,240,000.00 |
DisclosureSEC source: 0001144204-18-043691 · tv500791_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,115,614 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 09, 2018 Filed Aug 11, 2018 01:12 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 40,000 | $131.00 | $5,240,000.00 |
DisclosureSEC source: 0001144204-18-043690 · tv500789_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,115,614 Read SEC document |
| August 08, 2018 Filed Aug 11, 2018 01:13 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 50,000 | $131.05 | $6,552,500.00 |
DisclosureSEC source: 0001144204-18-043691 · tv500791_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,155,614 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 08, 2018 Filed Aug 11, 2018 01:12 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 50,000 | $131.05 | $6,552,500.00 |
DisclosureSEC source: 0001144204-18-043690 · tv500789_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,155,614 Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 01:41 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 100,000 | $131.00 | $13,100,000.00 |
DisclosureSEC source: 0001144204-18-042535 · tv500420_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,205,614 Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 01:40 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 100,000 | $131.00 | $13,100,000.00 |
DisclosureSEC source: 0001144204-18-042534 · tv500418_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,205,614 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 03, 2018 Filed Aug 8, 2018 01:41 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 50,000 | $131.60 | $6,580,000.00 |
DisclosureSEC source: 0001144204-18-042535 · tv500420_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,305,614 Read SEC document |
| August 03, 2018 Filed Aug 8, 2018 01:40 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 50,000 | $131.60 | $6,580,000.00 |
DisclosureSEC source: 0001144204-18-042534 · tv500418_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,305,614 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 918 | $131.43 | $120,652.74 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 12 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,355,614 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F13 · price: Weighted average price. Price range in multiple transactions was $131.30 to $131.55, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 3,003 | $130.86 | $392,972.58 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 11 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,356,532 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · price: Weighted average price. Price range in multiple transactions was $130.30 to $131.20, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 5,215 | $129.94 | $677,637.10 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 10 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,359,535 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $129.30 to $130.25, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 5,002 | $128.78 | $644,157.56 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 9 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,364,750 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $128.30 to $129.25, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 500 | $127.68 | $63,840.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 8 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,369,752 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $127.30 to $128.25, inclusive. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 918 | $131.43 | $120,652.74 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 12 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,355,614 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F14 · price: Weighted average price. Price range in multiple transactions was $131.30 to $131.55, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 3,003 | $130.86 | $392,972.58 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 11 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,356,532 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F13 · price: Weighted average price. Price range in multiple transactions was $130.30 to $131.20, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 5,215 | $129.94 | $677,637.10 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 10 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,359,535 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · price: Weighted average price. Price range in multiple transactions was $129.30 to $130.25, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 5,002 | $128.78 | $644,157.56 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 9 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,364,750 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $128.30 to $129.25, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 500 | $127.68 | $63,840.00 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 8 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,369,752 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $127.30 to $128.25, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 108 | $132.25 | $14,283.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 7 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,370,252 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $132.25 to $132.30, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,500 | $131.09 | $196,635.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,370,360 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $130.80 to $131.75, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 2,700 | $130.32 | $351,864.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,371,860 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $129.80 to $130.75, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,200 | $129.21 | $155,052.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,374,560 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $128.80 to $129.75, inclusive. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 4,743 | $128.05 | $607,341.15 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,375,760 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $127.70 to $128.65, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.